Is Hims GLP-1 FDA Approved? The Honest 2026 Answer (By Medication)

By Weight Loss Provider Guide Editorial TeamPublished

Last verified: May 16, 2026. Reverified monthly.

Quick answer to “Is Hims GLP-1 FDA approved?”

Yes — most GLP-1 medications you can get through Hims today are FDA-approved, but the answer depends on the exact medication. Wegovy® (pill and pen), Zepbound®, and Foundayo™ are FDA-approved for weight loss. Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes and can be prescribed off-label. Compounded semaglutide — which Hims still offers on a limited basis — is not FDA-approved. Hims as a platform is not FDA-approved either — that’s not how FDA approval works.

What we verified on May 16, 2026

Sources cited inline throughout. Anything we couldn’t fully verify is flagged.

Availability check: Hims says GLP-1s are not yet available in all 50 states. Verify your state during Hims intake before relying on the prices below. Prescription required.

Is Hims GLP-1 FDA Approved? The 30-Second Verdict

QuestionDirect answer
Is Hims itself FDA-approved?No. The FDA approves medications, not telehealth platforms. Hims is a licensed telehealth company that connects patients with providers who may prescribe FDA-approved medications.
Does Hims offer FDA-approved GLP-1 medications?Yes. Wegovy pill, Wegovy pen, Zepbound (KwikPen® and vial), Foundayo, Ozempic (injection and pill), and Mounjaro are all FDA-approved and accessible through Hims.
Is Hims's compounded semaglutide FDA-approved?No. Compounded drugs are not FDA-approved as finished products. Hims says it no longer advertises compounded GLP-1s and offers them only on a limited basis when a provider determines it's clinically necessary.
Is Hims always the cheapest path to an FDA-approved GLP-1?No. For Wegovy pill and Foundayo at the starting dose, Hims is competitive. For Zepbound, Hims's own pages show different prices on different listings — verify before checkout. For anyone with insurance, Ro is usually the cleaner path.

Last verified: May 16, 2026 against Hims’s public pricing pages, FDA approval records, Novo Nordisk and Eli Lilly announcements.

Why this question is so confusing in the first place

Hims sells access to a menu of GLP-1 medications. Some are brand-name drugs made by Novo Nordisk and Eli Lilly. Some are compounded drugs prepared by pharmacies under a different regulatory framework. They show up on the same product pages. They cost wildly different amounts. And they have very different regulatory status.

So the search “Is Hims GLP-1 FDA approved?” is really four separate questions:

  1. Is the FDA-approved-for-weight-loss medication on Hims actually FDA-approved? Yes — Wegovy pill, Wegovy pen, Zepbound, and Foundayo.
  2. Is the FDA-approved-for-diabetes-but-used-for-weight-loss medication FDA-approved? Yes, but only for diabetes. Off-label for weight loss. (Ozempic and Mounjaro.)
  3. Is Hims’s compounded semaglutide FDA-approved? No.
  4. Is the older Hims compounded oral semaglutide pill FDA-approved? It never was. Hims pulled it in February 2026 after FDA pressure — it’s a moot question for new customers.

The Hims GLP-1 FDA Status Matrix (verified May 16, 2026)

Every row was checked against the medication’s FDA approval record, Hims’s current public pricing pages, and the manufacturer’s direct cash-pay channel.

Hims medicationFDA statusApproved useHims starting price (med. only)Month 2+ all-in (with $149/mo membership)
Wegovy® Pill (oral semaglutide)✅ FDA-approvedChronic weight managementFrom $149/mo~$298/mo
Wegovy® Pen (injectable semaglutide)✅ FDA-approvedChronic weight management; also approved to reduce cardiovascular event riskFrom $199/mo~$348/mo
Zepbound® KwikPen® (tirzepatide multi-dose pen)✅ FDA-approvedChronic weight management; also FDA-approved for obstructive sleep apnea in adults with obesityFrom $199–$299/mo (varies by dose)~$348–$448/mo
Zepbound® Vial (single-dose tirzepatide)✅ FDA-approvedSame as Zepbound KwikPenFrom $199–$299/mo (verify by dose)~$348–$448/mo
Foundayo™ (orforglipron oral tablet)✅ FDA-approvedChronic weight managementFrom $149/mo~$298/mo
Ozempic® injection (semaglutide)✅ FDA-approved — for type 2 diabetes, not weight lossType 2 diabetes; prescribed off-label for weight lossFrom $199/mo at intro doses~$348/mo
Ozempic® Pill (oral semaglutide for diabetes)✅ FDA-approved — for type 2 diabetes, not weight lossImproving blood sugar in adults with type 2 diabetesFrom $149/mo~$298/mo
Mounjaro® (tirzepatide injection)✅ FDA-approved — for type 2 diabetes, not weight lossType 2 diabetes$1,899/mo on Hims (verify at checkout)~$2,048/mo
Compounded semaglutide injection❌ Not FDA-approvedN/A — not reviewed by FDA before marketingLimited availability since March 2026N/A
Compounded oral semaglutide pill (the $49 pill)❌ Not FDA-approved — and no longer offeredN/ADiscontinued February 2026N/A
Hims oral medication kits (non-GLP-1)❌ Not FDA-approved as finished productsComponents individually FDA-approved for other usesFrom ~$69/mo (10-month upfront plan)N/A

The takeaway: Being “on Hims” tells you nothing about FDA status. The specific medication on your prescription is what matters. Eight brand-name FDA-approved GLP-1 options are accessible through Hims today — the same medications you’d get at any pharmacy.

Check Hims's Current FDA-Approved GLP-1 Menu

Brand-name Wegovy pill, Wegovy pen, Foundayo, Zepbound, and Ozempic through one membership. $39 first month, then $149/month.

See Ro's FDA-Approved Pricing

Better if you want insurance coverage checked, prior authorization help, or annual membership savings.

Disclosure: We earn a commission when readers click through and start with a provider. It does not change our verification methodology or our willingness to call out where a provider’s pricing is confusing.

The four buckets, explained in plain English

Bucket 1 — FDA-approved for weight loss

Gold-standard, no-asterisk options. Reviewed by the FDA specifically for the purpose people use them for.

  • Wegovy® pill (oral semaglutide) — FDA-approved December 22, 2025
  • Wegovy® pen (injectable semaglutide) — first FDA-approved June 4, 2021; higher-dose 7.2 mg approved March 19, 2026
  • Zepbound® KwikPen® and vial (tirzepatide) — FDA-approved November 8, 2023; also approved for obstructive sleep apnea
  • Foundayo™ (orforglipron oral tablet) — FDA-approved April 1, 2026

Bucket 2 — FDA-approved for diabetes, used off-label for weight loss

100% FDA-approved — but for type 2 diabetes. A provider can legally prescribe them off-label for weight loss. Insurance is less likely to cover off-label use.

  • Ozempic® (semaglutide injection and oral pill) — FDA-approved for type 2 diabetes
  • Mounjaro® (tirzepatide injection) — FDA-approved for type 2 diabetes

Bucket 3 — Compounded GLP-1s (not FDA-approved)

Prepared by licensed compounding pharmacies under a different regulatory framework. The FDA does not review compounded drugs for safety, effectiveness, or quality before they reach patients.

Hims’s position changed dramatically in 2026. In March 2026 it announced it would no longer advertise compounded GLP-1s. It still offers them on a limited basis — only when a provider determines a patient’s clinical needs can’t be met by an FDA-approved option — but they’re no longer the default experience.

Bucket 4 — Stopped or legacy offers

If you found this page because you saw an article about Hims’s “$49 compounded semaglutide pill,” that product was launched in early February 2026, pulled within two days after FDA pressure, and is not currently available for new customers.

Is Hims the company FDA-approved?

No. The FDA approves medications, not telehealth companies.

Hims & Hers Health, Inc. is a publicly traded telehealth platform (NYSE: HIMS) that connects patients with licensed providers who may prescribe FDA-approved medications. Saying “Hims is FDA-approved” is like saying “your local pharmacy is FDA-approved” — it’s a category error.

Hims is, however, a licensed and regulated telehealth platform. Its providers are licensed in the states where they practice. Its pharmacies are generally licensed and overseen by state pharmacy boards. The platform is subject to FTC oversight for marketing claims and to state medical boards for clinical practice. So “Is Hims legitimate?” is a fair question — and the answer is yes, with the caveats throughout this page.

Which Hims GLP-1 medications are FDA-approved for weight loss specifically?

Four medications accessible through Hims are FDA-approved specifically for weight loss as of May 2026: Wegovy® pill, Wegovy® pen, Zepbound® (vial and KwikPen®), and Foundayo™. All four are manufactured by either Novo Nordisk or Eli Lilly, reviewed by the FDA, and identical in every respect to the same medications dispensed at retail pharmacies.

Wegovy® Pill through Hims

Oral semaglutide 25 mg — the first FDA-approved oral GLP-1 medication specifically approved for weight loss. FDA-approved December 22, 2025.

How Hims gets it: Direct partnership with Novo Nordisk announced March 9, 2026. Wegovy pill became available March 26, 2026 at $149/month at the starting dose — matching NovoCare’s direct cash-pay price.

On Hims: Available in 1.5 mg, 4 mg, 9 mg, and 25 mg doses. Starting at $149/month. Total Month 2 cost: ~$298/month all-in with membership.

Best for: Anyone who wants the FDA-approved oral path, prefers to avoid injections, and likes the Hims app experience. Pricing on Wegovy pill is competitive — Hims matches the cheapest available cash-pay price at the lowest dose.

Wegovy® Pen through Hims

The longest-tenured FDA-approved GLP-1 for weight loss — first approved June 4, 2021. Higher-dose 7.2 mg (Wegovy HD) approved March 19, 2026.

On Hims: Available in 0.25, 0.5, 1, 1.7, 2.4, and 7.2 mg doses. Starting price around $199/month at intro doses.

Best for: Patients who specifically want the injectable form, want the full dose range including the highest 7.2 mg dose, or have a preference for the Wegovy brand.

Zepbound® through Hims (Vial and KwikPen®)

Eli Lilly’s tirzepatide-based weight-loss medication. FDA-approved November 8, 2023 for chronic weight management. KwikPen announced February 23, 2026.

How Hims gets it: Hims doesn’t have a partnership with Eli Lilly. Hims’s own announcement explicitly states: “Access to Zepbound and Foundayo does not imply a partnership or affiliation with Eli Lilly and Company.” Providers send Zepbound prescriptions to LillyDirect® which fulfills and ships the medication.

On Hims: Listed from $199–$299/month medication-only at lower doses. Hims has shown conflicting Zepbound prices on different pages — see the pricing transparency section below. Verify the exact format and dose at checkout.

Best for: Patients who want Zepbound and value having it on the same telehealth platform. For most readers focused on price, Ro or LillyDirect directly can match or beat the Hims price, with insurance support added through Ro.

Foundayo™ through Hims

The first FDA-approved oral GLP-1 medication for weight loss that can be taken any time of day without food or water restrictions. FDA-approved April 1, 2026. Hims added it to its platform April 23, 2026 via the LillyDirect referral pathway.

On Hims: Lowest dose listed at $149/month — matching LillyDirect’s direct self-pay price. Total Month 2: ~$298/month all-in.

Best for: Patients who want an oral GLP-1 for weight loss without the morning-empty-stomach requirement of Wegovy pill.

Is Hims Ozempic (and Mounjaro) FDA-approved for weight loss?

No — but that’s a nuanced “no.”

Ozempic and Mounjaro are FDA-approved, full stop. But they’re approved for type 2 diabetes, not for weight loss. A provider can legally prescribe them off-label for weight loss if they decide it’s clinically appropriate. Off-label prescribing is legal, common, and often reasonable — but you should know what you’re taking and why it’s not on the FDA weight-loss label.

The FDA-approved-for-weight-loss semaglutide medication is Wegovy. The FDA-approved-for-weight-loss tirzepatide medication is Zepbound. Insurance is also less likely to cover off-label use for weight loss.

Mounjaro on Hims is listed at $1,899/month — a price that reflects brand-name tirzepatide without the weight-loss-specific discount programs Zepbound carries. For most readers, Zepbound is the more practical tirzepatide path.

Is Hims compounded semaglutide FDA-approved?

No.

Compounded semaglutide is not FDA-approved as a finished product — whether it comes through Hims or any other telehealth platform. The FDA does not review compounded drugs for safety, effectiveness, or quality before they reach patients.

What “compounded” actually means: Compounded medications are prepared by licensed compounding pharmacies, often combining or modifying existing drugs for specific patients. They exist in a different regulatory lane than FDA-approved drugs. The FDA has flagged ongoing concerns about compounded GLP-1 quality, storage, dosing errors, fraudulent labels, and salt-form variations.

Compounded semaglutide is not automatically fake and is not automatically illegal. Compounding can be legal in specific circumstances. But it is not FDA-approved, and it has not been individually evaluated by the FDA for safety, effectiveness, or quality.

What Hims says about compounded GLP-1s now (March 2026)

“The company will no longer advertise compounded GLP-1 offerings on its platform or in its marketing, and existing patients will have the opportunity to transition to FDA-approved medicines when determined clinically appropriate by their providers.”
See Hims's FDA-Approved GLP-1 Options

Wegovy pill, Wegovy pen, Foundayo, Zepbound, Ozempic — brand-name and FDA-approved.

The Hims, Novo Nordisk, and FDA timeline (so you know what just changed)

Hims’s GLP-1 business transformed in a roughly four-month window between February and May 2026. Here’s the timeline.

DateWhat happenedWhy it matters
Feb. 21, 2025FDA declared the semaglutide injection shortage resolvedReduced the broad shortage-based rationale for mass compounding of semaglutide
Sept. 9, 2025FDA issued a warning letter to Hims & Hers Health, Inc. dba HersFlagged claims implying compounded semaglutide products were the same as FDA-approved drugs
Early Feb. 2026Hims launched a $49 compounded oral semaglutide pillMarketed as a needle-free alternative
Feb. 6, 2026FDA announced intent to restrict GLP-1 active ingredients in non-FDA-approved compounded drugs, specifically naming Hims & HersSignaled aggressive federal enforcement
Feb. 7, 2026Hims voluntarily stopped offering the compounded oral semaglutide pillPulled two days after launch, citing FDA crackdown pressure and Novo's threatened legal action
March 9, 2026Hims & Hers announced a strategic shift; Novo Nordisk's patent infringement lawsuit was dismissed without prejudiceHims agreed to stop advertising compounded GLP-1s in exchange for access to FDA-approved Wegovy and Ozempic at cash-pay prices
March 26, 2026FDA-approved Wegovy pill, Wegovy pen, and Ozempic went live on the Hims platformWegovy pill starting at $149/month
April 1, 2026FDA approved Foundayo (orforglipron) — the second oral GLP-1 for weight lossFirst FDA-approved oral GLP-1 that can be taken any time of day without food or water restrictions
April 23, 2026Hims expanded its platform to allow providers to send prescriptions to LillyDirect® for Zepbound and FoundayoHims explicitly stated this is NOT a partnership with Eli Lilly

The short version: Hims spent most of 2025 selling compounded semaglutide. By spring 2026, that business model had been rendered impractical by FDA enforcement and patent litigation. Hims pivoted to FDA-approved brand-name access. That’s why a search for “Is Hims GLP-1 FDA approved?” returns conflicting older content.

How much does Hims FDA-approved GLP-1 actually cost?

Hims’s GLP-1 medication prices start at $149/month for the cheapest options. The Hims Weight Loss Membership is required and billed separately: $39 for the first month, then $149/month ongoing.

MedicationHims med. priceMonth 1 totalMonth 2+ total
Wegovy® pill (1.5 mg starting dose)$149/mo$188$298
Wegovy® pen (intro dose)~$199/mo$238$348
Foundayo™ pill (lowest dose)$149/mo$188$298
Ozempic® Pill$149/mo$188$298
Zepbound® vial (lowest dose)~$199–$299/mo$238–$338$348–$448
Zepbound® KwikPen®~$199–$299/mo (varies by dose)$238–$338$348–$448
Ozempic® injection (intro doses)~$199/mo$238$348
Mounjaro®$1,899/mo (as listed)$1,938$2,048

All prices verified May 16, 2026 against Hims’s public pricing pages. Membership is $39 first month / $149/month after. Medication is a separate line item.

What’s actually in the $149/month membership

  • Provider intake and ongoing care
  • 24/7 messaging access to the care team
  • Personalized nutrition guidance
  • In-app weight tracking
  • Dosage adjustments as treatment evolves
  • Side-effect management support

The membership does not cover the medication itself. The medication is a separate line item — genuinely confusing because many telehealth platforms bundle medication into their monthly price.

Verify before checkout

Hims’s pricing has shifted multiple times in the past 90 days as new medications have been added. The numbers above are current as of May 16, 2026. Verify the current pricing on hims.com/weight-loss for your specific medication, dose, and format before checkout.

See Hims's Current Wegovy and Foundayo Pricing

Membership: $39 first month, then $149/month. Medication billed separately. Prescription not guaranteed.

Does Hims accept insurance for GLP-1?

No.

Hims does not appear to accept insurance directly for GLP-1 medication or membership payment. Hims is a cash-pay path with FSA/HSA reimbursement possible depending on plan rules.

FSA/HSA at Hims: Hims recommends paying with a valid credit or debit card and submitting your receipt for reimbursement. FSA/HSA eligibility and coverage vary by plan provider — keep your prescription and diagnosis documentation ready.

If your insurance might cover GLP-1s

With a covered plan, your monthly copay could be as low as $25/month — a fraction of the cash-pay price. But your insurance company is unlikely to cover anything if you pay cash through Hims, because you’re not running the claim.

Ro’s insurance pathway: Ro publishes a free GLP-1 Insurance Coverage Checker that returns a personalized coverage report showing what your plan covers, your estimated copay, prior authorization requirements. Ro’s concierge team submits prior authorization paperwork on your behalf if your insurance covers GLP-1s. Hims doesn’t offer this service.

Check Your Insurance Coverage on Ro

Free Insurance Coverage Checker. Ro Body membership: $39 first month, then as low as $74/month with annual plan paid upfront.

The one thing Hims’s marketing pages won’t make easy to see

Hims shows you more than one price for the same Zepbound, depending on which page you land on.

Hims’s current Zepbound vial and Zepbound KwikPen product pages list prices in the $199–$299/month range (medication-only) at the lower doses. But other Hims listings and earlier reporting have shown the same medication at significantly higher numbers. The medication is the same FDA-approved Zepbound either way — manufactured by Eli Lilly, dispensed through LillyDirect, identical in active ingredient, dose, and labeling.

Why this happens: Hims has a direct partnership with Novo Nordisk that gives it negotiated cash-pay pricing on Wegovy and Ozempic. Hims does not have a partnership with Eli Lilly. Hims’s own announcement says so explicitly: “Access to Zepbound and Foundayo does not imply a partnership or affiliation with Eli Lilly and Company.” What Hims has with Lilly is a referral arrangement — providers on Hims send prescriptions to LillyDirect, which fulfills the medication.

The real Zepbound question isn’t “is Hims overpriced?” — it’s “what payment path matches your situation?” If you want cash-pay Zepbound through the Hims app and 24/7 care team messaging, Hims is fine — just verify the exact format and dose pricing at checkout. If you want the cleanest dose-by-dose Zepbound pricing with insurance support, Ro is the cleaner path.

Who should pick Hims for FDA-approved GLP-1?

PersonHims fitBetter path if not Hims
You want Wegovy pill at the lowest available cash-pay price✅ Strong fit
You want Foundayo at the lowest available cash-pay price✅ Strong fit
You want Ozempic Pill at $149/month✅ Strong fit
You want Wegovy pen and like the Hims app experience✅ Strong fit
You want Zepbound and your top priority is the cleanest pricing path⚠️ Verify carefullyRo Body Program (LillyDirect integration with transparent dose pricing)
You have insurance that might cover GLP-1 medications⚠️ Weak fitRo (free Insurance Coverage Checker, prior authorization concierge)
You want a no-membership-fee provider⚠️ Weak fitCompare cash-pay providers without membership fees
You want a compounded semaglutide option⚠️ Weak fitHims has deprioritized compounded — compare cash-pay compounded providers separately
You want a male-coded telehealth brand and don't mind paying for FDA-approved status✅ Strong fit

The thing Hims does best for FDA-approved GLP-1: the Novo Nordisk lineup (Wegovy pill, Wegovy pen, Ozempic, Ozempic Pill). That’s where the direct partnership gives Hims negotiated pricing that’s actually competitive. The thing Hims does less well: the Eli Lilly lineup (Zepbound, Mounjaro). Ro genuinely outperforms it there.

Hims vs Ro vs Sesame for FDA-approved GLP-1

ProviderBest forKey fact
HimsCash-pay shoppers who want the Novo Nordisk lineup or the Hims app experienceDirect partnership with Novo Nordisk for Wegovy and Ozempic. Membership $39 first month, then $149/month.
RoAnyone prioritizing insurance coverage, prior authorization help, or annual membership savingsFree GLP-1 Insurance Coverage Checker. Medication pricing matches NovoCare/LillyDirect direct. Membership $39 first month, then as low as $74/month with annual plan paid upfront.
Sesame CareProvider choice and Costco-member pricing on Wegovy and OzempicDirect provider booking model; Costco member discounted access to brand-name GLP-1s
Start with Hims

$39 first month membership. Medication billed separately.

Check Ro's Current GLP-1 Pricing

Get started for $39, then as low as $74/month with annual plan paid upfront. Free Insurance Coverage Checker.

What to verify before you pay (10-question checklist)

The checklist we’d want someone in our family to run through before signing up for any GLP-1 telehealth provider. Ordered by how much money or regret each question saves.

  1. 1

    Which exact medication am I being offered?

    Wegovy pill is not Wegovy pen is not Ozempic is not compounded semaglutide. Get the specific medication name.

  2. 2

    What is it FDA-approved for?

    Weight loss specifically, type 2 diabetes (used off-label), or compounded (not FDA-approved).

  3. 3

    Is it compounded or brand-name?

    This is the single biggest question to answer before you pay.

  4. 4

    Is the listed price medication-only?

    On Hims, yes — membership is separate.

  5. 5

    What's the total monthly cost in Month 2 (after intro pricing ends)?

    This is the number that matters for budgeting.

  6. 6

    Is this medication available in my state?

    Hims says GLP-1s are not yet available in all 50 states. Verify during intake.

  7. 7

    Where does the medication actually ship from?

    Hims fulfills some medications directly; Lilly medications ship from LillyDirect.

  8. 8

    Can I cancel the membership and the medication separately?

    Important if you want to pause the medication but keep the membership, or vice versa.

  9. 9

    What's the cancellation timing?

    Hims says cancellation must happen at least 48 hours before the next order date — orders already processing or shipped may not be stoppable.

  10. 10

    What are the side effects and contraindications for this specific medication?

    A licensed provider will go through these with you during the intake. Don't skip that conversation.

Begin Hims Eligibility Check

Provider review determines what medication, if any, may be prescribed. Prescription not guaranteed. Not available in all 50 states.

Take Our Free 60-Second GLP-1 Matching Quiz →

Tell us your medication preference, payment situation, and goal — matched in under a minute.

What Hims customers actually say about FDA-approved access

Review-scan sourced from Trustpilot (8,309 Hims reviews as of May 16, 2026). We use reviews to evaluate customer experience, not medical efficacy.

Positive review themes

Billing and shipping issues aside, customers who received FDA-approved medications report positive experiences with the medication itself. The drug, after all, is the same FDA-approved Wegovy or Foundayo that any pharmacy dispenses.

Consistent negative themes

Recent negative themes were predominantly operational: billing confusion, renewal/subscription complaints, shipping and carrier issues, and support communication delays.

“I absolutely feel a difference.” — Adam, 46 (Hims-published verified review)
“I feel lighter, have more energy.” — Roland, 43 (Hims-published verified review)

Per Hims’s own disclosure: customers featured in testimonials may have been compensated, results have not been independently verified, and individual results vary.

How we verified this page

Every factual claim was verified on May 16, 2026 against primary sources. Where we couldn’t fully verify a detail at checkout, we flag it.

Source categorySpecific sources
FDADrug approval announcements for Wegovy, Wegovy HD, Zepbound, Mounjaro, Foundayo, Ozempic; warning letter to Hims & Hers (Sept 9, 2025); FDA enforcement statement (Feb 6, 2026); compounding regulatory framework
Hims & Hers official sourceshims.com/weight-loss, hims.com/weight-loss/drug-pricing, hims.com/weight-loss/zepbound-kwikpen, hims.com/weight-loss/wegovy-pen, hims.com/weight-loss/ozempic-pill, investors.hims.com (March 9 and March 26, 2026), news.hims.com (April 23, 2026)
Novo NordiskWegovy pill FDA approval announcement; Hims & Hers partnership announcement
Eli LillyFoundayo FDA approval press release; Zepbound and Mounjaro labeling; LillyDirect pricing pages
RoRo Body Program pricing page; GLP-1 Insurance Coverage Checker
News verificationReuters reporting on Hims's compounded pill discontinuation; CNBC and CNN on FDA enforcement; Trustpilot review counts

Last verified: May 16, 2026. Next scheduled re-verification: June 16, 2026. We use Reddit and forums only for understanding what readers are confused about — never as evidence for medical or regulatory claims.

Frequently Asked Questions

Is Hims GLP-1 FDA approved?

Most GLP-1 medications you can get through Hims are FDA-approved as of May 2026. Wegovy pill, Wegovy pen, Zepbound (vial and KwikPen), Foundayo, Ozempic (injection and pill), and Mounjaro are all FDA-approved. Hims also offers compounded semaglutide on a limited basis, which is not FDA-approved. The medication on your prescription label — not the Hims brand — is what determines FDA status.

Is Hims itself FDA-approved?

No. The FDA approves medications, not telehealth companies. Hims is a licensed telehealth platform that connects patients with providers who may prescribe FDA-approved medications. 'Hims is FDA-approved' is a category error — FDA approval applies to specific drugs.

Is Hims compounded semaglutide FDA-approved?

No. Compounded GLP-1 medications are not FDA-approved as finished drug products. The FDA does not review compounded drugs for safety, effectiveness, or quality before they're marketed. Hims says it no longer advertises compounded GLP-1s and offers them only on a limited basis.

Is the Wegovy I'd get from Hims the real Wegovy?

Yes. The Wegovy dispensed through Hims is manufactured by Novo Nordisk, FDA-approved, and identical in active ingredient, dose, and labeling to the Wegovy dispensed at any retail pharmacy. The Hims and Novo partnership announced March 9, 2026 covers Wegovy pen (all approved doses) and Wegovy pill.

Is Hims Ozempic FDA-approved for weight loss?

No. Ozempic is FDA-approved for type 2 diabetes, not for weight loss. This is true whether you get Ozempic through Hims or any other pathway. A provider can prescribe Ozempic off-label for weight loss, but the FDA-approved-for-weight-loss semaglutide medication is Wegovy.

Why does Hims show different Zepbound prices?

Hims's current Zepbound vial and Zepbound KwikPen product pages list prices in the $199–$299/month range medication-only at lower doses, while other Hims listings and earlier 2026 reporting showed higher pricing. The medication is the same FDA-approved Zepbound either way — verify the exact format and dose before checkout. Hims membership is $39 first month, then $149/month, and medication is billed separately.

Does Hims accept insurance for GLP-1?

No, Hims does not accept insurance directly for GLP-1. Hims recommends paying with a valid credit or debit card and submitting your receipt for FSA/HSA reimbursement; FSA/HSA eligibility and coverage vary by plan provider. If you want insurance coverage, Ro offers a free Insurance Coverage Checker and prior authorization support.

How much does the Hims Weight Loss Membership cost?

The Hims Weight Loss Membership is $39 for the first month, then $149 per month ongoing. Medication is billed separately. Total Month 2 cost on the cheapest FDA-approved option (Wegovy pill, Foundayo, or Ozempic Pill at the starting dose) is approximately $298 per month all-in.

Is Hims's Foundayo FDA-approved?

Yes. Foundayo (orforglipron) was approved by the FDA on April 1, 2026 — the first FDA-approved oral GLP-1 medication for weight loss that can be taken any time of day without food or water restrictions. Hims accesses Foundayo through the LillyDirect referral pathway at $149/month at the lowest dose.

What did the FDA say about Hims specifically?

The FDA issued a warning letter to Hims & Hers Health, Inc. dba Hers on September 9, 2025 that specifically objected to marketing claims implying compounded semaglutide products were the same as FDA-approved drugs. In February 2026, the FDA announced enforcement intent against companies mass-marketing non-FDA-approved compounded GLP-1s and specifically named Hims & Hers. Hims stopped offering its compounded oral semaglutide pill within days of that announcement.

Is Hims available in every state?

No. Hims says GLP-1s are not yet available in all 50 states. State availability varies by medication and must be verified during the Hims intake or checkout flow.

Is Hims a legitimate company?

Yes. Hims & Hers Health, Inc. is a publicly traded telehealth platform (NYSE: HIMS) with a direct partnership with Novo Nordisk for Wegovy and Ozempic, and a referral arrangement with LillyDirect for Eli Lilly's GLP-1 medications. The FDA-approved medications dispensed through Hims are the same drugs dispensed at any retail pharmacy.

Final answer: should you start with Hims?

If you want FDA-approved Wegovy pill, Wegovy pen, Foundayo, or Ozempic Pill at competitive cash-pay pricing through a polished telehealth experience, Hims is a strong fit and one of the most legitimate options on the market today. If you want insurance to help cover your medication, the cleanest Zepbound pricing path, or annual membership savings, Ro Body Program is the smarter pivot.

See Hims's Current FDA-Approved Menu

Direct partnership with Novo Nordisk. Wegovy pill from $149/month. Membership: $39 first month, then $149/month.

Check Ro's Current GLP-1 Pricing

Get started for $39, then as low as $74/month with annual plan paid upfront. Free Insurance Coverage Checker.

Take Our Free 60-Second GLP-1 Matching Quiz →

Tell us your medication preference, payment situation, and goal — matched in under a minute.

Related guides on Weight Loss Provider Guide